Cargando…
Inflammasome lights up in systemic sclerosis
Systemic sclerosis (SSc) is a pro-fibrotic condition with a poorly understood aetiology. Evidence presented by Artlett et al. in this issue suggests that the microRNA miR-155 is key, with its involvement dependent on the NLRP3 inflammasome. This links epigenetic events with inflammasome signalling i...
Autores principales: | Henderson, John, O’Reilly, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604346/ https://www.ncbi.nlm.nih.gov/pubmed/28923085 http://dx.doi.org/10.1186/s13075-017-1420-z |
Ejemplares similares
-
Innate immunity in systemic sclerosis
por: O’Reilly, S.
Publicado: (2020) -
Circulating Gremlin-1 is elevated in systemic sclerosis
patients
por: O’Reilly, Steven
Publicado: (2021) -
Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
por: Henderson, John, et al.
Publicado: (2020) -
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
por: Hinchcliff, Monique, et al.
Publicado: (2020) -
Interleukin-6: a new therapeutic target in systemic sclerosis?
por: O'Reilly, Steven, et al.
Publicado: (2013)